Skip to main content

Table 1

From: Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer

Immune Cell Subset Baseline Post GC Post GC + Ipi Wilcoxon signed-rank text (p value)
     Post-GC versus Baseline Post-GC + Ipi versus Post GC Post-GC + Ipi verus Baseline
%CD3CD4 8.3 (5.5-13.10) 9.7 (5.1-16.4) 15.8 (9.4-27.0) 0.13 0.008 0.001
%CD3CD8 4.4 (2.6-6.7) 4.8 (3.1-7.6) 7.3 (4.2-13.5) 0.9 0.06 0.01
% Tregs 6.5 (4.1-7.4) 6.2 (5.2-8.8) 6.2 (4.4-8.0) 0.6 0.4 0.8
% Granulcytic MDSC 0.05 (0.01-.1) 0.04 (0.01-0.1) 0.04 (0.01-0.08) 0.7 0.8 0.4
% Monocytic MDSC 0.01 (0.007-0.03) 0.01 (0.004-0.02) 0.02 (0.007-0.03) 0.3 0.09 0.9